United States: Applicability Of "Amgen" Decision Should Be Very Narrow

Last Updated: March 14 2013
Article by Thomas E. Gilbertsen

When the Supreme Court issued its decision in Wal-Mart Stores, Inc. v. Dukes in 2011, defense lawyers hailed the case as a game-changer that would level the class action playing field in an arena that traditionally favored plaintiffs with various presumptions promoting class certification. Trying to limit its impact, plaintiff lawyers argued that Dukes was limited to employment cases, but we have since seen it relied upon in all manner of antitrust, advertising and other consumer protection class certification settings.

Is the shoe now on the other foot with the Supreme Court's recent plaintiff-friendly decision in Amgen Inc. v. Connecticut Retirement Plans & Trust Funds? In a majority opinion authored by Justice Ginsburg, the court ruled that plaintiffs need not prove materiality to invoke a fraud-on-the-market theory of classwide reliance in a securities class action. The fraud-on-the-market theory holds that an efficient stock market will reflect all publicly-available and material information about a given security, so classwide reliance on material statements may be presumed in cases pled under Section 10-b(5) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The problem with the materiality question in these cases is that it is both an element of the claim (therefore a merits issue ineligible for resolution on class certification) and also a predicate for invoking fraud-on-the-market to demonstrate that reliance is a common issue (and therefore seemingly crucial to class certification decision-making).

The question that made its way to the Supreme Court in Amgen is not whether fraud-on-the-market remains valid – and many have argued that it is not – but the relatively narrow question of when is the appropriate time to decide the materiality issue given its overlapping significance to class certification and the underlying merits? Federal circuits had split on this question, with some holding that plaintiffs must prove the materiality of challenged statements at the class certification stage in order to invoke the fraud-on-the-market theory that raises a presumption of class-wide reliance. See e.g. In re Salomon Analyst Metromedia Litig., 544 F.3d 474 (2d Cir. 2008). Other circuits held that since materiality is a Section 10(b) claim element, it need not (or cannot) be adjudicated at certification. See e.g. Schleicher v. Wendt, 618 F.3d 679 (7th Cir. 2010).

Amgen resolves the split and holds that since materiality is an element of securities fraud claims and is subject to an objective standard, this element presents a question common to all class members that should not be decided at the class certification stage. If materiality cannot be established later at trial, that failure disposes of the case with no surviving individual claims. By contesting materiality at class certification, defendants would be attempting to adjudicate the common issue in what the court called a forbidden "mini-trial." The decision emphasized that "Rule 23 grants courts no license to engage in free-ranging merits inquiries at the certification stage" and that "merits questions may be considered to the extent – but only to the extent – that they are relevant to determining whether Rule 23 prerequisites are satisfied." Amgen also mentions that predominance does not necessarily require that each claim element be susceptible to classwide proof in order to certify a class – an observation not necessary to the holding (that materiality was susceptible to common proof) and merely consistent with prevailing law that class damages need not be established by common proof. For further analysis, see "The Supreme Court's Decision in Amgen Reshapes the Securities Class Certification Battlefield," Venable Client Alert (March 1, 2013), available at http://www.venable.com/the-supreme-courts-decision-in-amgen-reshapes-the-securities-class-certification-battlefield-03-04-2013/

Although Amgen relates to a unique issue presented by security class actions, expect to see it cited by class action lawyers in antitrust, RICO, advertising and other consumer protection cases. One likely misapplication will be attempts to foreclose meaningful analysis of the reliance issues presented by materiality, causation and injury elements in these other settings. Yet, several antidotes are already plain. First, fraud-on-the-market theories are relegated to securities cases and routinely rejected in consumer fraud contexts. See e.g., McLaughlin v. American Tobacco Co., 522 F.3d 215 (2d Cir. 2008). Absent the presumption of an efficient market relying on all publicly available information, the materiality of a challenged representation or practice might still vary for differently situated purchasers or customers in a given antitrust or consumer protection class action.

Second, remember that even though materiality was a claim element overlapping with the certification issues presented in Amgen, it remained a common issue for the class because it was subject to an objective standard and if proof fails, no individual class member could recover. That litmus test will usually yield a contrary result in consumer cases. A good example is the transaction or loss causation element of a RICO, Clayton Act or state consumer fraud claim. These causation elements are often closely examined at the certification stage to determine whether common proof of injury-in-fact exists. Another example is when a class certification motion misclassifies "pattern or practice" allegations as a common issue presented for trial. Courts addressing these issues at class certification are not engaging in a "free-ranging merits inquiry" of the type forbidden by Amgen and earlier cases. Answering the question about whether a pattern or practice exists is necessary to seeing whether common proof is available and, unlike the materiality issue in a 10b-5 case, individual claims can survive a finding that no pattern or practice exists. The same holds true if a court finds that some plaintiffs cannot show causation – other individual cases survive.

Amgen's litmus test should generate negative results in most consumer class actions, so its impact outside the securities fraud arena should be limited.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions